Patents by Inventor Ying-Ta Wu

Ying-Ta Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9073941
    Abstract: The present invention provides compounds which are potent inhibitors against Lpd activity, PDH activity, and/or the growth of tubercle bacillus, and thus are useful in the treatment of tuberculosis infection and associated conditions. The present invention is further directed to in vitro- and in vzivo-based methods of inhibiting Lpd and/or PDH activity. In certain embodiments, these methods are useful in inhibiting Lpd and/or PDH activity key to a pathogen's survival.
    Type: Grant
    Filed: June 28, 2011
    Date of Patent: July 7, 2015
    Assignee: Academia Sinica
    Inventors: Chi-Huey Wong, Ying-Ta Wu
  • Publication number: 20130345223
    Abstract: The present invention provides compounds which are potent inhibitors against Lpd activity, PDH activity, and/or the growth of tubercle bacillus, and thus are useful in the treatment of tuberculosis infection and associated conditions. The present invention is further directed to in vitro- and in vzivo-based methods of inhibiting Lpd and/or PDH activity. In certain embodiments, these methods are useful in inhibiting Lpd and/or PDH activity key to a pathogen's survival.
    Type: Application
    Filed: June 28, 2011
    Publication date: December 26, 2013
    Applicant: Academia Sinica
    Inventors: Chi-Huey Wong, Ying-Ta Wu
  • Publication number: 20130158037
    Abstract: The present invention provides compounds which are potent inhibitors against Lpd activity, PDH activity, and/or the growth of tubercle bacillus, and thus are useful in the treatment of tuberculosis infection and associated conditions. The present invention is further directed to in vitro- and in vzivo-based methods of inhibiting Lpd and/or PDH activity. In certain embodiments, these methods are useful in inhibiting Lpd and/or PDH activity key to a pathogen's survival.
    Type: Application
    Filed: June 28, 2011
    Publication date: June 20, 2013
    Applicant: Academia Sinica
    Inventors: Chi-Huey Wong, Ying-Ta Wu
  • Publication number: 20130040952
    Abstract: Methods for identifying agents capable of disrupting a salt bridge in an influenza A virus nucleoprotein corresponding to the E339 . . . R416 salt bridge in SEQ ID NO:1, and thus the trimerization of the NP protein; and uses of such agents, e.g., small molecules and peptides, for inhibiting influenza virus replication and treating infection caused by influenza virus.
    Type: Application
    Filed: August 6, 2012
    Publication date: February 14, 2013
    Applicant: Academia Sinica
    Inventors: Chi-Huey Wong, Ming-Daw Tsai, Ying-Ta Wu, Yih-Shyun E. Cheng, Yu-Hou Chen, Yu-Fang Shen
  • Patent number: 6552007
    Abstract: A conjugate of somatostatin-spacer-drug and a method of making the same. The conjugate can be used to enhance an anti-cancer drug's specificity on the targeted tumor cells, thus increasing its therapeutic efficacy while reducing side-effects.
    Type: Grant
    Filed: December 11, 2000
    Date of Patent: April 22, 2003
    Assignee: Academia Sinica
    Inventors: Shui-Tein Chen, Ying-Ta Wu, Chun-Ming Huang
  • Publication number: 20020094964
    Abstract: An conjugate of somatostatin-spacer-drug and a method of making the same. The conjugate can be used to enhance an anti-cancer drug's specificity on the targeted tumor cells, thus increasing its therapeutic efficacy while reducing side-effects.
    Type: Application
    Filed: December 11, 2000
    Publication date: July 18, 2002
    Inventors: Shui-Tein Chen, Ying-Ta Wu, Chun-Ming Huang